An Oct. 7 meeting was part of the FDA's review process of pending applications for IQOS ILUMA. "We encourage the FDA to continue efforts to establish a timely scientific review process for smoke-free ...
Philip Morris International (NYSE:PM) is urging the U.S. Food and Drug Administration to allow the company to continue marketing its heated tobacco products in the U.S. as a “modified risk tobacco ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results